Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-24-010088

CHIEF OPERATING OFFICER gave up 521 shares (to pay taxes)

  • CHIEF OPERATING OFFICER acquired 1,773 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Tessari Eben CHIEF OPERATING OFFICER 2024-04-01 Option exercise +1,773 124,620 D
Tessari Eben CHIEF OPERATING OFFICER 2024-04-01 Shares withheld for taxes −521 $19.70 $10,264 124,099 D
Derivatives
Tessari Eben CHIEF OPERATING OFFICER 2024-04-01 Option exercise · Restricted Share Unit −1,773 5,318 D
Loading xslF345X05/form4-04032024_090445.xml…